表紙
市場調查報告書
商品編碼
1034831

介入心臟病學及末稍血管設備的全球市場(2021年∼2028年)

Global Interventional Cardiology and Peripheral Vascular Devices Market - 2021-2028

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球介入心臟病學及末稍血管設備的市場調查,市場定義和概要,市場成長的各種影響因素分析,法律規章、償付環境,市場規模的變化、預測,產品類型、用途、終端用戶、地區/主要國家等各種區分的明細,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 調查手法、調查範圍

第2章 市場定義、概要

第3章 摘要整理

第4章 市場動態

  • 市場影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球介入心臟病學及末稍血管設備市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 全球介入心臟病學及末稍血管設備市場:COVID-19分析

第7章 全球介入心臟病學及末稍血管設備市場:各產品類型

  • 介入導管
  • 導管導引線
  • 支架
  • PTCA球囊擴張術
  • 旋切術設備
  • 慢性完全閉塞設備
  • 合成外科用移植片
  • 栓塞保護設備
  • IVC過濾器
  • 其他

第8章 全球介入心臟病學及末稍血管設備市場:各用途

  • 先天性心臟病的根治術
  • 冠狀動脈血栓摘出術
  • 血管成形術
  • 瓣環成形術
  • 經皮閥修復
  • 其他

第9章 全球介入心臟病學及末稍血管設備市場:各終端用戶

  • 醫院
  • 門診病人手術中心
  • 其他

第10章 全球介入心臟病學及末稍血管設備市場:各地區

  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第11章 全球介入心臟病學及末稍血管設備市場:競爭情形

  • 主要的展開、策略
  • 企業佔有率分析
  • 產品基準
  • 值得注意的主要企業的清單
  • 具顛覆性技術的企業的清單

第12章 全球介入心臟病學及末稍血管設備市場:企業簡介

  • Lepu Medical Technology
  • InSitu Technologies
  • Comed
  • Spectranetics
  • Hexacath
  • Medtronic Inc.
  • Shenzhen MicroApproach Medical Technology
  • Teleflex Incorporated

第13章 DataM

目錄
Product Code: DMMD4259

Market Overview

Interventional cardiology and peripheral vascular devices are the types of devices that are used to treat different cardiovascular conditions with the help of catheters, with minimal invasion. These devices are specially used to treat patients related to heart problems.

The global interventional cardiology and peripheral vascular devices market size was valued US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Market Dynamics

Rapid technological advancements in peripheral vascular devices are expected to drive market growth.

Peripheral arterial disease (PAD) has changed over time as the prevalence of associated risk factors and co-morbidities-including the increase in insulin-dependent diabetes and the changing dynamic of tobacco use-has evolved. Endovascular therapies specifically have grown with the explosion of new technologies. There are numerous options for patients with disease amenable to endovascular therapy. For instance, balloon angioplasty and stenting have provided a strong base for endovascular therapy, and atherectomy developed as an additional option in anatomic locations not normally amenable to stents, including the common femoral artery or popliteal artery. Atherectomy has become widely adopted across specialties with four main function methods: directional, rotational, orbital, and laser atherectomy.

In contrast, directional atherectomy functions using a carbide cutting blade with varying sizes to customize the type of lesion. A distal protection device is placed, and then the blade rotates and is moved across the lesion. As the blade is advanced, the particles are contained by the protection device.

Restraint:

The approval processes in low-income countries are stringent for interventional cardiology & peripheral vascular devices, as these are highly specialized devices introduced in the body. The cost of stents increases with advancements in technology. For instance, the price of bioabsorbable stents is twice as much as the cost of drug-eluting stents. The cost of drug-coated balloons is also high compared to other interventional cardiology and peripheral vascular devices. Moreover, the lack of hospital infrastructure and easy availability of alternative treatments can challenge the interventional cardiology and peripheral vascular devices market.

COVID-19 Impact Analysis

The epidemic caused by the SARS-CoV-2 virus resulted in a global lockdown and wreaked havoc on interventional cardiology and peripheral vascular devices. There is an increased risk for people suffering from heart diseases to contract the virus, especially those prone to heart attacks, and there is a high probability of death if the virus is not diagnosed on time. Moreover, there are serious concerns about the long-term worsening of cardiovascular health outcomes due to a lack of timely diagnosis. There are very few multiple stakeholders for patient access to cardiovascular treatment and therapeutics. Also, the devices like stethoscopes may increase the risk of the virus when used to listen and identify specific heart sounds such as clicks, murmurs and rubs of the Covid-19 positive patient. Additionally, the pandemic is interrupting the medical supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

PTCA Balloons segment is expected to hold the largest market share in interventional cardiology and peripheral vascular devices market.

The PTCA balloons segment accounted for the largest market share in 2020. Its advantages in coronary atrial disease treatment, including reduced artery narrowing that improves the blood flow, lead to higher product preference. For instance, Coronary angioplasty, also called percutaneous coronary intervention, is a procedure used to open clogged heart arteries. Angioplasty uses a tiny balloon catheter inserted in a blocked blood vessel to help widen it and improve blood flow to the heart. Angioplasty is often combined with the placement of a small wire mesh tube called a stent. The stent helps prop the artery open, decreasing its chance of narrowing again. Most stents are coated with medication to help keep the artery open (drug-eluting stents). Rarely, bare-metal stents are used.

Moreover, angioplasty can improve symptoms of blocked arteries, such as chest pain and shortness of breath. It is also often used during a heart attack to quickly open a blocked artery and reduce the amount of damage to the heart. Therefore, the above statements have increased the demand for interventional cardiology and peripheral vascular devices. Thus, the segment is expected to hold the largest market share in the forecast period.

Valvuloplasty segment is expected to hold the largest market share in interventional cardiology and peripheral vascular devices market.

The valvuloplasty segment accounted for the largest market share in 2020. According to the Centers for Disease Control and Prevention, approximately 13% of the population suffers from valvular heart disease. Valvuloplasty offers comprehensive applications in severe valve narrowing and narrowing of the pulmonary and mitral valves, among others. Therefore, with the rise in valvular diseases, the segment will observe substantial growth during the forecast timeline.

Geographical Analysis

North America region holds the largest market share in the global interventional cardiology and peripheral vascular devices market

In 2020, North America accounted for the highest revenue share. The increasing prevalence of diabetes, increase in the aging population, development of minimally invasive procedures, product launches by the market players and easy availability of reimbursement are some factors that the market is expected to boost in the forecast period. For instance, according to the Centers for Disease Control and Prevention, The death rate for diabetes jumped nearly 14 percent between 2019 and 2020. In 2019, the diabetes death rate was 21.6 per 100,000 populations, rising to 24.6 in 2020. Therefore, high blood glucose from diabetes can damage blood vessels and the nerves that control the heart and blood vessels. Over time, this damage can lead to heart disease. People with diabetes tend to develop heart disease at a younger age than people without diabetes.

Moreover, Biotronik, on September 29, 2021, announced it received U.S. Food and Drug Administration (FDA) approval for its Orsiro® Mission bioabsorbable polymer drug-eluting stent system (BP-DES). Hence, the above statements have increased the demand for interventional cardiology and peripheral vascular devices. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the interventional cardiology and peripheral vascular devices market are Teleflex Incorporated, InSitu Technologies, Comed, Spectranetics, Hexacath, Lepu Medical Technology, Shenzhen MicroApproach Medical Technology and Medtronic Inc.

Lepu Medical Technology (Beijing) Co., Ltd.:

Overview:

Lepu Medical Technology (Beijing) Co., Ltd. was established in 1999. It is specialized in developing, manufacturing and distributing high-tech medical devices and equipment. Lepu Medical has grown into a global leading group company in the fields of cardiovascular, neurovascular and peripheral vascular interventions, structural heart diseases, surgical cardiology, cardiac rhythm management, anesthesia and intensive care, in vitro diagnostics and general surgery with products include coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, cardiac in vitro diagnosis products, anesthetic products, angiography systems and surgical staplers.

Product Portfolio:

Supercross™ PTA Balloon Dilatation Catheters: PTA balloon catheter is indicated for percutaneous transluminal angioplasty (PTA) in patients with obstructive disease of peripheral arteries.

Why Purchase the Report?

Visualize the composition of the global interventional cardiology and peripheral vascular devices market segmentation by product type, application, end user and region highlighting the key commercial assets and players.

Identify commercial opportunities in global interventional cardiology and peripheral vascular devices market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global interventional cardiology and peripheral vascular devices market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global interventional cardiology and peripheral vascular devices market report would provide an access to an approx.45+ market data table, 40+ figures and 180pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Interventional Cardiology and Peripheral Vascular Devices Market - By Product type

Interventional Catheters

Guidewires

Stents

PTCA Balloons

Atherectomy Devices

Chronic Total Occlusion Devices

Synthetic Surgical Grafts

Embolic Protection Devices

IVC filters

Others

Global Interventional Cardiology and Peripheral Vascular Devices Market - By Application

Congenital Heart Defect Correction

Coronary Thrombectomy

Angioplasty

Valvuloplasty

Percutaneous Valve Repair

Others

Global Interventional Cardiology and Peripheral Vascular Devices Market - By End user

Hospitals

Ambulatory Surgical Centers

Others

Global Interventional Cardiology and Peripheral Vascular Devices Market - By Region

North America

South America

Europe

Asia Pacific

Middle East & Africa

Table of Contents

1. Global Interventional Cardiology and Peripheral Vascular Devices Market - Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Interventional Cardiology and Peripheral Vascular Devices Market - Market Definition and Overview

3. Global Interventional Cardiology and Peripheral Vascular Devices Market - Executive Summary

  • 3.1. Market Snippet by Product type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End user
  • 3.4. Market Snippet by Region

4. Global Interventional Cardiology and Peripheral Vascular Devices Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rapid technological advancements in peripheral vascular devices are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The approval processes in low-income countries are stringent for interventional cardiology & peripheral vascular devices, as these are highly specialized devices introduced in the body. The cost of stents increases with advancements in technology. For instance, the price of bioabsorbable stents is twice as much as the cost of drug-eluting stents. The cost of drug-coated balloons is also high compared to other interventional cardiology and peripheral vascular devices. Moreover, the lack of hospital infrastructure and easy availability of alternative treatments can challenge the interventional cardiology and peripheral vascular devices market.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Interventional Cardiology and Peripheral Vascular Devices Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Interventional Cardiology and Peripheral Vascular Devices Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion
  • 6.7. Others

7. Global Interventional Cardiology and Peripheral Vascular Devices Market - By Product type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 7.1.2. Market Attractiveness Index, By Product type Segment
  • 7.2. Interventional Catheters*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Guidewires
  • 7.4. Stents
  • 7.5. PTCA Balloons
  • 7.6. Atherectomy Devices
  • 7.7. Chronic Total Occlusion Devices
  • 7.8. Synthetic Surgical Grafts
  • 7.9. Embolic Protection Devices
  • 7.10. IVC filters
  • 7.11. Others

8. Global Interventional Cardiology and Peripheral Vascular Devices Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Congenital Heart Defect Correction*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Coronary Thrombectomy
  • 8.4. Angioplasty
  • 8.5. Valvuloplasty
  • 8.6. Percutaneous Valve Repair
  • 8.7. Others

9. Global Interventional Cardiology and Peripheral Vascular Devices Market - By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. Global Interventional Cardiology and Peripheral Vascular Devices Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Global Interventional Cardiology and Peripheral Vascular Devices Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch
  • 11.5. List of Company with disruptive technology

12. Global Interventional Cardiology and Peripheral Vascular Devices Market- Company Profiles

  • 12.1. Lepu Medical Technology*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. InSitu Technologies
  • 12.3. Comed
  • 12.4. Spectranetics
  • 12.5. Hexacath
  • 12.6. Medtronic Inc.
  • 12.7. Shenzhen MicroApproach Medical Technology
  • 12.8. Teleflex Incorporated (LIST NOT EXHAUSTIVE)

13. Global Interventional Cardiology and Peripheral Vascular Devices Market - DataM

  • 13.1. Appendix
  • 13.2. About Us
  • 13.3. Contact Us